## Abstract To assess the clinical value of whole-body positron emission tomography (PET) with [18F]fluorodeoxyglucose (FDG) in recurrent colorectal cancer, 35 patients were studied: 15 had resectable liver metastases, one a resectable lung metastasis, eight resectable pelvic recurrence, eight a pr
โฆ LIBER โฆ
Impact of18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences
โ Scribed by A. Imdahl; M. J. Reinhardt; E. U. Nitzsche; M. Mix; A. Dingeldey; A. Einert; P. Baier; E. H. Farthmann
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 92 KB
- Volume
- 385
- Category
- Article
- ISSN
- 1435-2451
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Clinical value of whole-body positron em
โ
G. Beets; Professor F. Penninckx; C. Schiepers; L. Filez; L. Mortelmans; R. Kerr
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 587 KB
Usefulness 18F-FDG positron emission tom
โ
Young-Kyu Kim; Kwang-Woong Lee; Seong Yeon Cho; Sung-Sik Han; Seong Hoon Kim; Se
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 91 KB
18 F-fluoro-2-deoxy-D-glucose ( 18 F-FDG) positron emission tomography (PET)/computed tomography (CT) has recently been shown to be able to predict a poor outcome after liver transplantation (LT) for patients with hepatocellular carcinoma (HCC). However, there are few reports on the usefulness of PE
[18F]-fluorodeoxyglucose positron emissi
โ
Ehab M. Kamel; Matthias T. Wyss; Mathias K. Fehr; Gustav K. von Schulthess; Gerh
๐
Article
๐
2003
๐
Springer-Verlag
๐
English
โ 322 KB
Potential impact of [18F]3'-deoxy-3'-flu
โ
D. L. Francis; D. Visvikis; D. C. Costa; T. H. A. Arulampalam; C. Townsend; S. K
๐
Article
๐
2003
๐
Springer
๐
English
โ 263 KB
Positron emission tomography with 18F-fl
โ
Munetaka Takekuma; Makoto Maeda; Takachika Ozawa; Kazuhiko Yasumi; Tatsuo Torizu
๐
Article
๐
2005
๐
Springer
๐
English
โ 266 KB
Positron emission tomography with 18F-fl
โ
Yukihiro Hama
๐
Article
๐
2006
๐
Springer
๐
English
โ 186 KB